目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
What's New in This Update?
Research Methodology
Geographic Breakdown

Chapter- 2: Summary and Highlights
Market Outlook

Chapter- 3: Market Overview
Introduction
History of Nucleic Acid Drugs
Regulations
COVID-19 Impact Analysis on the RNAi Drug Delivery Markets

Chapter- 4: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities

Chapter- 5: Nucleic Acid Drug Delivery Technology Market by Type
Encapsulation
Conjugates
Table 7 : Direct Methods of Insertion into the Cell
Table 8 : Advantages and Disadvantages of Various Kinds of Drug Delivery Systems
Figure 15 : Global Market Shares of Nucleic Acid Drug Delivery Sytems, by Type, 2022
Figure 16 : Drug Delivery of Nucleic Acid Drugs, by Types

Chapter- 6: Market Breakdown by Application
Drug Development and Discovery
Therapeutic Application
Table 15 : Global Market for Nucleic Acid Drug Delivery, by Application, Through 2028

Chapter- 7: Market Breakdown by Route of Administration
Figure 23 : Market Breakdown by Route of Administration Types and Subtypes
Table 17 : Routes of Administration for Nucleic Acid Drugs
Table 18 : Global Market for Nucleic Acid Drug Delivery, by Route of Aministration, Through 2028

Chapter- 8: Market Breakdown by Molecules
Small Interfering Ribonucleic Acid
Antisense Oligonucleotide
Messenger RNA
Others
Table 19 : Characteristics of Different Molecule Types for Nucleic Acid Drug
Table 20 : Global Market for Nucleic Acid Drug Delivery, by Molecule Type, Through 2028

Chapter- 9: Market Breakdown by Therapeutic Area
Oncology
Rare and Genetic Diseases
Central Nervous System
Respiratory
Other Disease
Table 24 : Global Market for Nucleic Acid Drug Delivery, by Therapeutic Area, Through 2028
Figure 26 : Global Market Shares of Nulceic Acid Drug Delivery Systems, by Therapeutic Area, 2022

Chapter- 10: Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World
Table 25 : Global Market for Nucleic Acid Drug Delivery, by Region, Through 2028
Figure 27 : Global Market for Nucleic Acid Drug Delivery, by Region, 2020-2028

Chapter- 11: Environmental, Social and Governance in the Biotechnology Sector
Key Environmental, Social and Governance Issues in the Biotechnology Industry
Biotechnology Industry Environmental, Social and Governance Performance Analysis
Consumer Perspective on ESG in Biotechnology
Case Study
Concluding Remarks from BCC Research

Chapter- 12: Emerging Technologies and Developments
Drug Delivery to Lungs
Nanotechnology
Use of Artificial Intelligence and Machine Learning

Chapter- 13: Clinical Trial and Patent Analysis
Clinical Trials Analysis
Patent Analysis

Chapter- 14: Mergers and Acquisitions and Funding Outlook
Start-Up Funding in Nucleic Acid Delivery Technology
Table 37 : Collaboration in Nucleic Acid Drug Delivery Market, 2021-2023

Chapter- 15: Competitive Intelligence
Figure 43 : Global Market Shares of Nucleic Acid Drug Deivery, by Various Growth Strategies, 2022
Table 39 : Collaborations in the Nucleic Acid Drug Delivery Market, 2021-2023
Table 40 : Clinical Trials and Approvals in the Nucliec Acid Drug Delivery Market, 2021-2023
Table 41 : Other Strategic Developments in Nucleic Acid Drug Delivery Market, 2021-2023

Chapter- 16: Company Profiles
ALNYLAM PHARMACEUTICALS INC.
ARCTURUS THERAPEUTICS INC.
ARBUTUS BIOPHARMA CORP.
ARROWHEAD PHARMACEUTICALS INC.
BENITEC BIOPHARMA
CELLECTA INC.
ELEVEN THERAPEUTICS
GENEVANT SCIENCES CORP.
IONIS PHARMACEUTICALS INC.
MIRIMUS, INC.
NOVO NORDISK
NANODE THERAPEUTICS INC.
OLIX PHARMACEUTICALS
PHIO PHARMACEUTICALS CORP.
SILENCE THERAPEUTICS PLC
SIRNAOMICS INC.
SOMAGENICS, INC.